Prognostic performance of FIGO 2023 endometrial carcinoma staging: a comparison to FIGO 2009 staging in the setting of known and unknown molecular classification

Documenti analoghi

• Folate receptor alpha ( FRα / FOLR1 ) and HER2 immunohistochemical staining in high‐grade endometrial carcinoma with aberrant p53 expression
  di: Austin McHenry, et al.
  Pubblicazione: (2025)
• Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐ and high‐stage tumours
  di: Austin McHenry, et al.
  Pubblicazione: (2024)
• The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile
  di: Mona Alafraidi, et al.
  Pubblicazione: (2024)
• SOX17 expression in mesonephric‐like adenocarcinomas and mesonephric remnants/hyperplasia of the female genital tract: Expanding its utility as a Müllerian biomarker
  di: Xiaoming Zhang, et al.
  Pubblicazione: (2024)
• Practical guidance for assessing and reporting lymphovascular space invasion (LVSI) in endometrial carcinoma
  di: Elke E M Peters, et al.
  Pubblicazione: (2024)